Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 158

Similar articles for PubMed (Select 16880314)

2.

Mothers' attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study.

Waller J, Marlow LA, Wardle J.

Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1257-61.

3.

[Cervical cancer prevention: the impact of HPV vaccination].

Monsonégo J.

Gynecol Obstet Fertil. 2006 Mar;34(3):189-201. Epub 2006 Mar 10. Review. French.

PMID:
16529969
4.

[Vaccination against human papillomavirus for the prevention of cervical cancer].

Quint WG, ter Harmsel WA, van Doorn LJ.

Ned Tijdschr Geneeskd. 2006 Jun 24;150(25):1380-4. Review. Dutch.

PMID:
16841585
5.

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.

Rambout L, Hopkins L, Hutton B, Fergusson D.

CMAJ. 2007 Aug 28;177(5):469-79. Epub 2007 Aug 1. Review.

6.

Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.

Adams M, Jasani B, Fiander A.

Vaccine. 2007 Apr 20;25(16):3007-13. Epub 2007 Jan 18. Review.

PMID:
17292517
7.
8.

Human papillomavirus vaccines versus cervical cancer screening.

Stanley M.

Clin Oncol (R Coll Radiol). 2008 Aug;20(6):388-94. doi: 10.1016/j.clon.2008.04.006. Epub 2008 Jun 5. Review.

PMID:
18538554
9.
10.

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.

11.

Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial.

Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, Alvarez FB, Bautista OM, Jansen KU, Barr E.

Obstet Gynecol. 2006 Jan;107(1):18-27. Erratum in: Obstet Gynecol. 2006 Jun;107(6):1425.

PMID:
16394035
12.

HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives.

Castellsagué X, Schneider A, Kaufmann AM, Bosch FX.

Gynecol Oncol. 2009 Dec;115(3 Suppl):S15-23. doi: 10.1016/j.ygyno.2009.09.021. Epub 2009 Oct 12.

PMID:
19819540
13.

Clinical role of cervical cancer vaccination: when and whom to vaccinate?

Torné A, Alonso I, Puig-Tintoré LM, Pahisa J.

Gynecol Oncol. 2008 Sep;110(3 Suppl 2):S15-6. doi: 10.1016/j.ygyno.2008.06.015. Epub 2008 Jul 17.

PMID:
18635253
14.

The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Taiwan.

Dasbach EJ, Insinga RP, Yang YC, Pwu RF, Lac C, Elbasha EH.

Asian Pac J Cancer Prev. 2008 Jul-Sep;9(3):459-66.

15.

[Human papillomavirus: a vaccine against cervical carcinoma uterine].

Franceschi S.

Epidemiol Prev. 2002 May-Jun;26(3):140-4. Italian.

PMID:
12197051
16.

HPV and HPV vaccine.

Centers for Disease Control and Prevention.

J Med Assoc Ga. 2007;96(1):45-7. No abstract available.

PMID:
17621907
17.

Prophylactic human papillomavirus vaccines: will they do their job?

Stanley M.

J Intern Med. 2010 Mar;267(3):251-9. doi: 10.1111/j.1365-2796.2009.02193.x.

PMID:
20201919
18.

Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial.

Gudmundsdóttir T, Tryggvadóttir L, Allende M, Mast TC, Briem H, Sigurdsson K.

Acta Obstet Gynecol Scand. 2003 Apr;82(4):345-50.

PMID:
12716319
19.
20.

Strategies for the prevention of cervical cancer by human papillomavirus vaccination.

Williamson AL, Passmore JA, Rybicki EP.

Best Pract Res Clin Obstet Gynaecol. 2005 Aug;19(4):531-44. Epub 2005 Apr 12. Review.

PMID:
16150392
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk